Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v25-FR Version v8-EN
Language French English
Date Updated 2018-10-29 2017-09-13
Drug Identification Number 00778338 00778338
Brand name AXID AXID
Common or Proper name AXID 150mg CAPS 100 AXID 150mg CAPS 100
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients NIZATIDINE NIZATIDINE
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-08-09 2017-08-09
Actual start date 2017-08-09 2017-08-09
Estimated end date 2018-10-12 2017-09-20
Actual end date 2018-10-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments